SAN FRANCISCO--(BUSINESS WIRE)--Counsyl, a health technology company that offers DNA screening for diseases that can impact women, men, and their children, announced today that the company has screened more than 500,000 patients, doubling the number of patients served since May 2014.
“Counsyl has experienced tremendous growth, and reaching this milestone is a testament to our dedication to make screening more broadly accessible,” said Ramji Srinivasan, co-founder and CEO at Counsyl. “We’re incredibly humbled that we've earned the trust of so many patients and physicians at critical times in their lives, and we're still in the very early stages of what's possible. We still have the opportunity to serve millions of people each year who are planning to get pregnant, are pregnant, or are at-risk for or newly diagnosed with serious cancers.”
To meet the growing demand for genetic screening, Counsyl has grown its staff 30 percent since June 2014. The company has also continued to increase accessibility for patients by working with more than 8,000 medical professionals, as well as increasing affordability. Counsyl’s payor network covers approximately 80 percent of patients with commercial insurance, and Counsyl offers an affordable self-pay option for those who are underinsured.
Since founding in 2007 and launching their first product in 2009, Counsyl’s genetic counselors have logged more than 10,000 hours of counseling, achieving an average satisfaction rating of 4.9 out of 5.0 for genetic counseling sessions. This puts Counsyl’s genetic counseling scale right in the ballpark of the 2014-2015 U.S. News and World Report Best Hospitals for gynecology. Each Counsyl screen includes a consultation with a board-certified genetic counselor who is available on-demand to patients, instead of requiring them to wait days or weeks for an appointment. Counsyl’s genetic counselors help patients understand results and work with physicians to determine next steps for each patient.
Counsyl offers three types of genetic screening, all of which require a doctor’s prescription. The Inherited Cancer Screen helps patients learn about their risk of developing certain preventable cancers, such as breast and ovarian cancer or colon cancers associated with Lynch syndrome. The Family Prep Screen looks at a couple’s DNA for serious inherited diseases that they can unknowingly pass on to their future children. With access to this information, couples can better prepare as they look to grow their family. The Informed Pregnancy Screen provides early insight into a baby’s genetic development using non-invasive methods and can be performed in the first trimester.
For more information on Counsyl, please visit www.counsyl.com.
Counsyl is a health technology company that offers DNA screening for men, women, and their children. Their philosophy is simple: focus on diseases where advanced knowledge makes a difference in health outcomes, whether it’s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead.
The Counsyl team includes an accomplished group of problem-solvers — top engineers, scientists, and designers — who are taking the lead on building the modern clinical laboratory. By using automation technology and software to reimagine the clinical lab, Counsyl has unlocked a scalable platform that generates more meaningful health insights for a fraction of the cost at industry-leading speed. Counsyl pairs this high tech approach with a high touch solution for delivering test results: patient reports created with a design sensibility, and supplemented with a genetic counseling service that rivals the top 10 US hospitals.
Counsyl has screened more than 500,000 patients and served over 8,000 health care professionals in its CLIA-certified, CAP-accredited and NYS CLEP-permitted clinical laboratory. From the purely mechanical to the profoundly human, Counsyl strives to make DNA screening truly accessible to everyone.